In a study comprising 258 male gout patients and 111 males undergoing annual check-ups, elevated levels of leptin and plasminogen activator inhibitor-1, coupled with reduced ADPN and ADPN/leptin ratio, were noted in patients with gout (p < 0.05, respectively). Here, LEP is linked to gout.